Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-26-128728

Stakes reported in this filing

Reporting person Shares Of the class
ADAR1 Capital Management, LLC 6,648,027 8.7%
Daniel Schneeberger 6,648,027 8.7%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…